Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Adjunct, Aerodrome, Aldrich, Arie, Aziyo, Barbara, billion, breakfast, broadly, CDMO, Childhood, chronic, combat, composed, confidence, Costa, Culture, density, Deputy, diagnosed, disrupted, disruption, diversified, EC, epidemic, extend, Fidelio, Floor, fraction, geographically, geography, GGT, globe, glycaemic, glycemic, Hammersmith, heightened, home, Horizon, inadequate, induced, instructed, Jay, Julio, lab, Latin, lessee, marker, Mayer, MCAP, metformin, methodology, Miami, Miller, monotherapy, mutual, nationwide, network, night, nineteen, Nyxoah, outbreak, pandemic, parallel, pattern, pilot, pivotal, Postgraduate, postpone, presidential, proclamation, Programme, proton, Psychology, quarantine, redemption, regrant, reissued, repay, Rica, Rosenstock, Royal, SA, Sigma, Skyler, slandered, SME, Southwestern, spending, spread, spreading, staffing, timeline, TLA, topline, TrialNet, waiting, week, Western, worsen, Wuhan
Removed:
absorption, abstract, added, adirector, administered, AG, appointedChief, appointedPresident, began, beta, calendar, California, call, cardiovascular, charged, clamp, collectability, commence, community, confirmed, consecutive, direction, driven, Eisenberg, emptying, focusing, footnote, gastric, HCW, Hilla, hypoparathyroidism, hypothesized, improved, inflammation, ingested, intake, intravenously, largely, lessor, mouth, nonclinical, noted, occurring, Officerand, owed, par, placement, platform, progressed, quantifying, reducing, release, relief, satiety, sensitivity, stimulated, stimulating, stream, supplemented, therapy, toxicology, unchanged, vascular, Wainwright
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Composite Copy of Certificate of Incorporation, As Amended As of January 22, 2013, Corrected February 8, 2013, As Amended As of July 25, 2014, Corrected September 5, 2017 and As Further Amended As of August 3, 2020
- 3.2 Composite Copy of Certificate of Incorporation, As Amended As of January 22, 2013, Corrected February 8, 2013, As Amended As of July 25, 2014, Corrected September 5, 2017 and As Further Amended As of August 3, 2020
- 4.4 Description of Securities
- 23.1 Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm.
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
ORMP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-236194 and 333-190497) and Form S-8 (Nos. 333-244380, 333-234303, 333-213835, 333-199120, 333-190222 and 333-163919) of Oramed Pharmaceuticals Inc. of our report dated November 24, 2020 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
November 24, 2020 | Certified Public Accountants (lsr.) |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il